| Identifier |
20190319_nanos_sciplatform3_08_slides |
| Title |
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice |
| Creator |
Timothy McCulley; Jinglan Pei; Paris Sidiropoulos; Christine Birchwood; Jennie Best; John Stone; Sebastian Unizony |
| Affiliation |
(TM) The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; (JP) (PS) (CB) (JB) Genentech, Inc., South San Francisco, California; (JS) (SU) Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, Massachusetts |
| Subject |
Vascular Disorders |
| Description |
The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated with TCZ in a real-world setting. |
| Date |
2019-03 |
| Language |
eng |
| Format |
application/pdf |
| Format Creation |
Microsoft PowerPoint |
| Type |
Text |
| Source |
2019 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 2019: Scientific Platform III |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6090s4x |
| Setname |
ehsl_novel_nam |
| ID |
1455040 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6090s4x |
